Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Director effectiveness assessment

13 Feb 2020 07:00

RNS Number : 8370C
Barclays PLC
13 February 2020
 

 

13 February 2020

Barclays PLCBarclays Bank PLC

Director effectiveness assessment: disclosure of regulatory investigation

In accordance with the UK Corporate Governance Code, all of the current Directors of Barclays PLC will be submitting themselves for election or re-election at the Annual General Meeting to be held on 7 May 2020, and will be unanimously recommended by the Board for election or re-election as appropriate. Further information in this regard will be set out in the Notice of Meeting which will be published in due course.

In deciding whether to recommend Jes Staley for re-election, the Board has carried out its usual formal and rigorous performance assessment, which it does in respect of the effectiveness of each of the Directors. As part of its determination in respect of Mr. Staley, the Board has had regard to media reports in the past 6 months that have highlighted historical links between Mr. Staley and Jeffrey Epstein.

As has been widely reported, earlier in his career Mr. Staley developed a professional relationship with Mr. Epstein. In the summer of 2019, in light of the renewed media interest in the relationship, Mr. Staley volunteered and gave to certain executives, and the Chairman, an explanation of his relationship with Mr. Epstein. Mr. Staley also confirmed to the Board that he has had no contact whatsoever with Mr. Epstein at any time since taking up his role as Barclays Group CEO in December 2015.

The relationship between Mr. Staley and Mr. Epstein was the subject of an enquiry from the Financial Conduct Authority ("FCA"), to which the Company responded. The FCA and the Prudential Regulation Authority subsequently commenced an investigation, which is ongoing, into Mr. Staley's characterisation to the Company of his relationship with Mr. Epstein and the subsequent description of that relationship in the Company's response to the FCA.

Based on a review, conducted with the support of external counsel, of the information available to us and representations made by Mr. Staley, the Board (the Executive Directors having been recused) believes that Mr. Staley has been sufficiently transparent with the Company as regards the nature and extent of his relationship with Mr. Epstein. Accordingly, Mr. Staley retains the full confidence of the Board, and is being unanimously recommended for re-election at the Annual General Meeting.

The Board will continue to cooperate fully with the regulatory investigation, and will provide a further update as and when it is appropriate to do so.

- ENDS -

For further information, please contact:

Investor Relations

Media Relations

Adam Strachan

Tom Hoskin

+1 212 526 8442

+44 (0) 20 7116 4755

James Johnson 

+44 (0)20 7116 7233

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group.

For further information about Barclays, please visit our website home.barclays 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLLLFBLLBBBB
Date   Source Headline
30th Mar 20217:00 amRNSResults of placing in Gamma Communications
29th Mar 20214:47 pmRNSProposed placing in Gamma Communications
16th Mar 20217:00 amRNSResults of placing in Wizz Air
15th Mar 20214:44 pmRNSProposed placing in Wizz Air
9th Mar 20215:25 pmRNSFCA Combined Supplement 2 of 2020
18th Feb 20216:25 pmRNSAnnual Report on Form 20-F
18th Feb 202110:47 amRNSFCA Supplement 1_2020 Barclays Bank Ireland BP16
18th Feb 202110:46 amRNSFCA Supplement 2_2020_Barclays Bank Ireland BP9
18th Feb 202110:39 amRNSFCA Combined Supplement 1_2020 - RNS Announcement
18th Feb 20217:00 amRNSAnnual Financial Report
17th Feb 20217:00 amRNSResults of placing in Hargreaves Lansdown
16th Feb 20214:41 pmRNSProposed placing in Hargreaves Lansdown
29th Jan 20213:16 pmRNSPublication of Suppl.Prospcts
15th Jan 20214:42 pmRNSNotice to Holders of Results of Adjourned Meeting
7th Jan 20213:45 pmRNSFinal Result of Tender Offer to Noteholders
21st Dec 20203:45 pmRNSResult of Tender Offer to Noteholders
16th Dec 20206:27 pmRNSNotice to Security Holders of Results of Meetings
16th Dec 20206:27 pmRNSNotice of Security Holders Adjourned Meetings
16th Dec 20206:26 pmRNSNotice to Security Holders of Results of Meetings
9th Dec 20203:31 pmRNSPublication of a Prospectus
7th Dec 20205:52 pmRNSTender Offer to Noteholders
24th Nov 20201:45 pmRNSAmendment - Notice to holders of Securities
23rd Nov 20207:37 amRNSNotice to holders of outstanding Securities
5th Oct 202010:28 amRNSPost Stab- Commerzbank AT1 No Stabilisation Notice
1st Oct 20207:00 amRNSDirectorate Change
15th Sep 20207:00 amRNSResults of placing in Watches of Switzerland Group
14th Sep 20204:50 pmRNSProposed placing in Watches of Switzerland Group
8th Sep 20208:23 amRNSPre-Stabilisation Notice - Commerzbank AT1
28th Aug 20207:00 amRNSNotice of Redemption
26th Aug 20205:24 pmRNSPublication of BP2 pursuant to the GSSP
12th Aug 202011:36 amRNSArticle 8
12th Aug 202011:10 amRNSArticle 8
7th Aug 202010:50 amRNSPublication of Suppl.Prospcts
29th Jul 20207:00 amRNSHalf-year Report
17th Jul 20202:59 pmRNSPost Stabilisation Notice Exxon - no stabilisation
17th Jul 202011:32 amRNSAnnouncement of Partial Redemption
30th Jun 20202:20 pmRNSPublication of 2020 GSSP Base Prospectus 16
26th Jun 20202:23 pmRNSArticle 8
23rd Jun 20203:06 pmRNSExxon Pre-Stabilisation Notice
22nd Jun 202010:22 amRNSArticle 8
19th Jun 20204:51 pmRNSArticle 8
12th Jun 202012:56 pmRNSBarclays PLC Post Stabilisation Notice
20th May 20205:11 pmRNSArticle 8
15th May 20204:51 pmRNSPublication of Suppl.Prospcts
15th May 20202:32 pmRNSBarclays PLC T2 Pre-Stabilisation Notice
14th May 20203:22 pmRNSArticle 8
12th May 202011:00 amRNSDoc re. rights attached to debt securities
4th May 20204:45 pmRNSPublication of a Prospectus
6th Apr 20205:18 pmRNSDelisting Notice
31st Mar 20201:05 pmRNSNotice to Noteholders Series 11492 Class MV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.